Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. LFWD

(LFWD)

0.00

0.00 (0.00%)

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile

Stock details

Previous close
6.43$
Day's range
6.13 - 6.5$
52-week range
4.14 - 21.78$
Volume
7 768
Average volume
14 608
Beta
0.47
EPS (TTM)
-18.51
PE ratio (TTM)
N/A
Market cap
9 826 468
Shares outstanding
1 528 222
Dividend yield
N/A
Next earnings date
2026-05-07
Sector
Healthcare
Industry
Medical Devices

About the company

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit... read more
CEO
William Grant
Country
Israel
IPO Date
2014-09-12
Employees
81
Fiscal Year End
January - December
Website
https://golifeward.com

Revenue Breakdown

ReWalk Personal, ReWalk Rehabilitation, AlterG Anti-Gravity System, MyoCycle, and ReStore / 77.90%
Service and Warranty / 14.01%
Lease / 8.08%

News

No Data

There are no news for this stock.

Chart: LFWD

Loading Chart...

Overall Score

3.7 / 1037%
Financial Strength
5.6
Profitability
1.8
Effectiveness
1
Growth
4.6
Forecast
9.5
Valuation
5.1

Financial Strength

NAMERATIOINDUSTRY5Y TRENDSCORE
Current ratio1.313.407.0
Quick ratio0.842.525.0
Debt to Equity0.521.117.0
Debt to Assets0.191.588.0
Interest coverage-11.054.331.0
Weighted average score5.6

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)
Values in USD (B=Billions, M=Millions, K=Thousands)
METRIC2022202320242025TTM
Total Revenue6M14M26M22M22M
Gross Profit2M4M8M8M8M
Operating Income-19M-20M-20M-17M-17M
Net Income-20M-22M-29M-20M-20M
EBITDA-19M-19M-16M-17M-17M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAMERATIOINDUSTRY5Y TRENDSCORE
Gross margin %21.4156.14
5.0
Operating margin %-100.73-0.60
1.0
Net margin %-105.25-70.45
1.0
EBITDA margin %-99.31-53.99
1.0
Cash flow margin %-69.97-20.44
1.0
Weighted average score1.8

Net Margin

Effectiveness

NAMERATIOINDUSTRY5Y TRENDSCORE
ROA-75.79-27.02
1.0
ROE-120.52-50.60
1.0
ROIC-118.64-19.95
1.0
ROCE-29.25-16.09
1.0
Weighted average score1.0

Estimated EPS vs Actual EPS

Forecast

NAMEREVENUE GROWTHEPS GROWTHSCORE
Current quarter14.7277.659.0
Next quarter13.8281.329.0
Current year36.6781.3310
Next year72.8555.4710
Weighted average score9.5

Analyst Rating

Growth

NAMEREVENUENET INCOMEEPSFCFSCORE
Q/Q-17.97-68.7-24.997.182.0
Y/Y-32.656586.2710.157.0
3y average74.17-4.216.330.664.5
5y average50.14-12.8814.25-8.95.0
Weighted average score4.6

Revenue Growth Rate vs. Industry

Valuation

NAMERATIOINDUSTRY5Q TRENDSCORE
P/EN/A14.30
1.0
PEG (5yr expected)N/A2.36
1.0
P/S0.279.12
9.4
P/B0.8215.43
8.8
Weighted average score5.1

DCF Model

DCF Model PeriodN/A
Discount rateN/A
Perpetual growth rateN/A
Revenue 5 year CAGRN/A
FCF 5 year CAGRN/A
Fair value$
Stock price6.43$

Dividend

NAMECURRENTINDUSTRYSCORE
Dividend yield0.00N/A1.0
Payout ratio0.00N/A1.0
5-year dividend growth rateN/AN/A1.0
Years of dividend increaseN/AN/A1.0
Weighted average score1.0

Fair Value

Fair Value

$1

UndervaluedStock priceOvervalued

$6.43

Economic Moat

NAMESCALESCORE
Market shareNone1.0
Intangible assetsNone1.0
Switching costsNone1.0
Network effectNone1.0
Economies of scaleNone1.0
Weighted average score1.0
Dividend
1
Economic Moat
1

Octagon View

Strength & Weakness

Total debt $4.4M significantly exceeds cash reserves ($2.4M), raising financial stability concerns

Total current assets $15.8M exceed Total current liabilities $12.0M, highlighting excellent liquidity

Debt-to-equity ratio (0.5) is well below the industry average (1.1), showcasing prudent financial management

Interest coverage ratio (-11.1x) is dangerously low, suggesting debt repayment risks

Negative free cash flow -$3.6M limits the company's ability to reinvest or pay down debt